Salman Abdulaziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Salman Abdulaziz has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Ibrahim Al-Sanouri
Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2 shared publications- Jack Wei Chieh Tan
Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
2 shared publications Maie Al-Shahid
King Faisal Heart Institute, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
2 shared publicationsNabil Abou-Shala
Department of Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2 shared publications- Saleh Fares Al Ali
Department of Emergency Medicine, Zayed Military Hospital Abu Dhabi, UAE
2 shared publications - Vivek Kakar
Cleveland Clin Abu Dhabi, Crit Care Inst, Abu Dhabi, U Arab Emirates
2 shared publications
Latest Publications
- 25 February 2026
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 32 (8) , 1265-1272
Antimicrobial stewardship during extracorporeal membrane oxygenation: challenges and new perspectives
- 25 February 2026
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 32 (8) , 1265-1272
Antimicrobial stewardship during extracorporeal membrane oxygenation: challenges and new perspectives
- 12 January 2026
- Published by Wiley in Artificial Organs
- Vol. 50 (5) , 647-659
Diagnostic Imaging Challenges During Extracorporeal Membrane Oxygenation
Background: Extracorporeal membrane oxygenation (ECMO) is a critical life support therapy for severe cardiac and respiratory failure, but it is associated with thromboembolic, hemorrhagic, and neurological complications. Diagnostic imaging is essential for early detection and management of these events; however, conventional modalities such as contrast enhanced computed tomography (CT) are often limited by the risks of transporting unstable patients and by ECMO related hemodynamic alterations that may distort contrast distribution, particularly in peripheral veno arterial (VA‐ECMO). Aim: This review aims to evaluate current diagnostic imaging strategies and emerging non invasive technologies that may improve the detection and management of ECMO related complications, with a focus on contrast enhanced CT, bedside echocardiography, and novel neuroradiological tools. Methods: A narrative synthesis was conducted examining diagnostic approaches applicable to ECMO patients, including contrast enhanced CT, transesophageal echocardiography (TEE), low field bedside magnetic resonance imaging (MRI), and electrical impedance tomography. The review emphasizes physiological considerations, technical limitations, and potential clinical applications. Results: TEE enables real time assessment of cardiac–ECMO interactions and identification of the watershed zone in VA‐ECMO, supporting individualized flow optimization. Low field bedside MRI reduces transport related risks and may enhance early detection of cerebral complications. Electrical impedance tomography provides dynamic, radiation free monitoring of regional ventilation in ARDS patients on veno venous VV‐ECMO. Despite promising performance characteristics, these technologies remain underutilized in routine practice. Conclusion: Integrating advanced bedside imaging modalities with traditional diagnostic tools may significantly improve the safety and accuracy of monitoring in ECMO patients. Broader adoption and further technological refinement could enhance early complication detection and support more personalized ECMO management.
- 12 January 2026
- Published by Wiley in Artificial Organs
- Vol. 50 (5) , 647-659
Diagnostic Imaging Challenges During Extracorporeal Membrane Oxygenation
Background: Extracorporeal membrane oxygenation (ECMO) is a critical life support therapy for severe cardiac and respiratory failure, but it is associated with thromboembolic, hemorrhagic, and neurological complications. Diagnostic imaging is essential for early detection and management of these events; however, conventional modalities such as contrast enhanced computed tomography (CT) are often limited by the risks of transporting unstable patients and by ECMO related hemodynamic alterations that may distort contrast distribution, particularly in peripheral veno arterial (VA‐ECMO). Aim: This review aims to evaluate current diagnostic imaging strategies and emerging non invasive technologies that may improve the detection and management of ECMO related complications, with a focus on contrast enhanced CT, bedside echocardiography, and novel neuroradiological tools. Methods: A narrative synthesis was conducted examining diagnostic approaches applicable to ECMO patients, including contrast enhanced CT, transesophageal echocardiography (TEE), low field bedside magnetic resonance imaging (MRI), and electrical impedance tomography. The review emphasizes physiological considerations, technical limitations, and potential clinical applications. Results: TEE enables real time assessment of cardiac–ECMO interactions and identification of the watershed zone in VA‐ECMO, supporting individualized flow optimization. Low field bedside MRI reduces transport related risks and may enhance early detection of cerebral complications. Electrical impedance tomography provides dynamic, radiation free monitoring of regional ventilation in ARDS patients on veno venous VV‐ECMO. Despite promising performance characteristics, these technologies remain underutilized in routine practice. Conclusion: Integrating advanced bedside imaging modalities with traditional diagnostic tools may significantly improve the safety and accuracy of monitoring in ECMO patients. Broader adoption and further technological refinement could enhance early complication detection and support more personalized ECMO management.
- 4 September 2025
- Published by SAGE Publications in Perfusion
Residual blood management after ECMO weaning: Reinfuse, salvage, or discard?
Extracorporeal membrane oxygenation (ECMO) supports patients with severe refractory cardiac or respiratory failure but managing residual circuit blood after weaning lacks consensus. After decannulation, the oxygenator and circuit retain approximately 500–700 mL of blood, depending on tubing length, cannula size, and circuit configuration. Clinicians usually choose among direct reinfusion, cell-salvage processing, or disposal. Direct reinfusion maintains circulating red cell mass and may help avert allogeneic transfusion, especially in borderline cases, but carries the risk of reintroducing free hemoglobin, inflammatory mediators, microthrombi, and air emboli. Cell salvage offers an intermediary strategy by removing harmful elements through washing and centrifugation, but introduces delays in volume return, mechanical red cell damage, loss of platelets and clotting factors, and added cost. Discarding the blood eliminates reinfusion risks but increases reliance on banked blood, which poses risks such as immunomodulation, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), and resource depletion. Modified CPD blood bags have shown promise for temporarily storing blood from ECMO or RRT circuits, particularly in neonatal and pediatric patients. Additionally, residual blood salvage during ECMO circuit changes, an often-overlooked opportunity for autologous transfusion, deserves greater emphasis. In the absence of standardized guidelines, current practice remains heterogeneous. We advocate prospective, multicenter trials comparing these strategies with endpoints including transfusion requirements, hemolysis and inflammation biomarkers, fluid balance, organ dysfunction scores, cost implications, and survival. Evidence-based protocols will enhance patient safety, reduce costs, and standardize ECMO care.
- 4 September 2025
- Published by SAGE Publications in Perfusion
Residual blood management after ECMO weaning: Reinfuse, salvage, or discard?
Extracorporeal membrane oxygenation (ECMO) supports patients with severe refractory cardiac or respiratory failure but managing residual circuit blood after weaning lacks consensus. After decannulation, the oxygenator and circuit retain approximately 500–700 mL of blood, depending on tubing length, cannula size, and circuit configuration. Clinicians usually choose among direct reinfusion, cell-salvage processing, or disposal. Direct reinfusion maintains circulating red cell mass and may help avert allogeneic transfusion, especially in borderline cases, but carries the risk of reintroducing free hemoglobin, inflammatory mediators, microthrombi, and air emboli. Cell salvage offers an intermediary strategy by removing harmful elements through washing and centrifugation, but introduces delays in volume return, mechanical red cell damage, loss of platelets and clotting factors, and added cost. Discarding the blood eliminates reinfusion risks but increases reliance on banked blood, which poses risks such as immunomodulation, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), and resource depletion. Modified CPD blood bags have shown promise for temporarily storing blood from ECMO or RRT circuits, particularly in neonatal and pediatric patients. Additionally, residual blood salvage during ECMO circuit changes, an often-overlooked opportunity for autologous transfusion, deserves greater emphasis. In the absence of standardized guidelines, current practice remains heterogeneous. We advocate prospective, multicenter trials comparing these strategies with endpoints including transfusion requirements, hemolysis and inflammation biomarkers, fluid balance, organ dysfunction scores, cost implications, and survival. Evidence-based protocols will enhance patient safety, reduce costs, and standardize ECMO care.
- Top Cited PapersOpen Access
- 7 January 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (1)
Mechanical Circulatory Support for Massive Pulmonary Embolism
Up to 50% of patients with pulmonary embolism (PE) experience hemodynamic instability and approximately 70% of patients who die of PE experience an accelerated cascade of symptoms within the first hours of onset of symptoms, thus necessitating rapid evaluation and intervention. Venoarterial extracorporeal membrane oxygenation and other ventricular assist devices, depending on the hemodynamic derangements present, may be used to stabilize patients with massive PE refractory to initial therapies or with contraindications to other interventions. Given the abnormalities in both pulmonary circulation and gas exchange caused by massive PE, venoarterial extracorporeal membrane oxygenation may be considered the preferred form of mechanical circulatory support for most patients. Venoarterial extracorporeal membrane oxygenation unloads the right ventricle and improves oxygenation, which may not only help buy time until definitive treatment but may also reduce myocardial ischemia and myocardial dysfunction. This review summarizes the available clinical data on the use of mechanical circulatory support, especially venoarterial extracorporeal membrane oxygenation, in the treatment of patients with massive PE. Furthermore, this review also provides practical guidance on the implementation of this strategy in clinical practice.
- 7 January 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (1)
Top Cited PapersOpen AccessMechanical Circulatory Support for Massive Pulmonary Embolism
Up to 50% of patients with pulmonary embolism (PE) experience hemodynamic instability and approximately 70% of patients who die of PE experience an accelerated cascade of symptoms within the first hours of onset of symptoms, thus necessitating rapid evaluation and intervention. Venoarterial extracorporeal membrane oxygenation and other ventricular assist devices, depending on the hemodynamic derangements present, may be used to stabilize patients with massive PE refractory to initial therapies or with contraindications to other interventions. Given the abnormalities in both pulmonary circulation and gas exchange caused by massive PE, venoarterial extracorporeal membrane oxygenation may be considered the preferred form of mechanical circulatory support for most patients. Venoarterial extracorporeal membrane oxygenation unloads the right ventricle and improves oxygenation, which may not only help buy time until definitive treatment but may also reduce myocardial ischemia and myocardial dysfunction. This review summarizes the available clinical data on the use of mechanical circulatory support, especially venoarterial extracorporeal membrane oxygenation, in the treatment of patients with massive PE. Furthermore, this review also provides practical guidance on the implementation of this strategy in clinical practice.
- Open Access
- 17 August 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Circulatory Extracorporeal Membrane Oxygenation Support for High-Risk Acute Pulmonary Embolism
- 17 August 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Open AccessCirculatory Extracorporeal Membrane Oxygenation Support for High-Risk Acute Pulmonary Embolism
- Open Access
- 24 April 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Acute MI-Cardiogenic Shock and Endorsed by the Asian Pacific Society of Interventional Cardiology
In the Asia-Pacific region, acute MI (AMI) is associated with a high rate of cardiogenic shock (CS), which increases the risk of mortality several-fold. The management of AMI-CS in the region is heterogeneous and lacks consensus. Hence, an Asian Pacific Society of Cardiology working group developed consensus recommendations on the management of AMI-CS in the Asia-Pacific region. The Asian Pacific Society of Cardiology expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Consensus recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were ‘agree’ or ‘neutral.’ The resulting statements, which have been endorsed by the Asian Pacific Society of Interventional Cardiology and affirmed by the Society for Cardiovascular Angiography and Interventions, provide guidance on the diagnosis, assessment and treatment of patients with AMI-CS among clinical practitioners in the region.
- 24 April 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Open AccessAsian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Acute MI-Cardiogenic Shock and Endorsed by the Asian Pacific Society of Interventional Cardiology
In the Asia-Pacific region, acute MI (AMI) is associated with a high rate of cardiogenic shock (CS), which increases the risk of mortality several-fold. The management of AMI-CS in the region is heterogeneous and lacks consensus. Hence, an Asian Pacific Society of Cardiology working group developed consensus recommendations on the management of AMI-CS in the Asia-Pacific region. The Asian Pacific Society of Cardiology expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Consensus recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were ‘agree’ or ‘neutral.’ The resulting statements, which have been endorsed by the Asian Pacific Society of Interventional Cardiology and affirmed by the Society for Cardiovascular Angiography and Interventions, provide guidance on the diagnosis, assessment and treatment of patients with AMI-CS among clinical practitioners in the region.
- 2 April 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (11) , 2702-2711
Current Status of Adult Post–Cardiac Surgery Critical Care in Saudi Arabia
- 2 April 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (11) , 2702-2711
Current Status of Adult Post–Cardiac Surgery Critical Care in Saudi Arabia
- 1 May 2021
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 57 (5) , 106334
Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial
- 1 May 2021
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 57 (5) , 106334
Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial
- 1 January 2021
- Published by Medknow in Saudi Journal of Kidney Diseases and Transplantation
- Vol. 32 (3) , 869-874
Renal Tubular Acidosis in Critically Ill Patients with Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
The coronavirus disease 2019 (COVID-19) infection associated with multisystemic involvement including renal manifestations has been described in the literature. The recent data show a high mortality rate of 60%–90% once renal function begins to deteriorate. We report on three patients who were admitted to intensive care unit due to severe COVID-19 acute respiratory distress syndrome and developed distal renal tubular acidosis. The three COVID-19 patients had hyperchloremic acidosis which was investigated thoroughly through a biochemical analysis of arterial blood gases and urine test as well as serological tests for autoimmune diseases and chronic infections, in addition to renal ultrasound. Metabolic acidosis was managed through repeated doses of intravenous sodium bicarbonate therapy; however, continuous renal replacement therapy was initiated for two refractory cases. We found that severe COVID-19 infection may be accompanied by hyperchloremic acidosis due to the cytopathic damage of the distal renal tubules, making the buffering system nonefficient and if not managed adequately, it may lead to poor prognosis.
- 1 January 2021
- Published by Medknow in Saudi Journal of Kidney Diseases and Transplantation
- Vol. 32 (3) , 869-874
Renal Tubular Acidosis in Critically Ill Patients with Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
The coronavirus disease 2019 (COVID-19) infection associated with multisystemic involvement including renal manifestations has been described in the literature. The recent data show a high mortality rate of 60%–90% once renal function begins to deteriorate. We report on three patients who were admitted to intensive care unit due to severe COVID-19 acute respiratory distress syndrome and developed distal renal tubular acidosis. The three COVID-19 patients had hyperchloremic acidosis which was investigated thoroughly through a biochemical analysis of arterial blood gases and urine test as well as serological tests for autoimmune diseases and chronic infections, in addition to renal ultrasound. Metabolic acidosis was managed through repeated doses of intravenous sodium bicarbonate therapy; however, continuous renal replacement therapy was initiated for two refractory cases. We found that severe COVID-19 infection may be accompanied by hyperchloremic acidosis due to the cytopathic damage of the distal renal tubules, making the buffering system nonefficient and if not managed adequately, it may lead to poor prognosis.